Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
NEURIVE logo — A front runner for digital medical platform

NEURIVE

A front runner for digital medical platform

Founded 2018 Korea South Korea South 6 employees Seed Total: $1.20B Digital Health, Health and Wellness

General Information

Company Name NEURIVE
Founded Year 2018
Location Korea South Korea South
Employees 6
Industries Digital Health, Health and Wellness
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with NEURIVE. To contact NEURIVE, visit neurive.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NEURIVE compare?

A PDF of NEURIVE and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NEURIVE soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NEURIVE

NEURIVE is a promising startup, positioning itself as a front runner for digital medical platforms. Established in 2018, the company focuses on developing cutting-edge technologies tailored to the specific needs of the medical sector. Its core expertise lies in the creation of electroceuticals and digital medical treatment devices. NEURIVE's primary area of interest is non-invasive vagus nerve stimulation technology, and the company's research and development efforts are directed towards the advancement of electroceuticals and other innovative technologies to revolutionize medical devices and medicine. Headquartered in South Korea, NEURIVE recently secured a significant milestone by raising a KRW1.00B Seed Round investment on 26 September 2021. The noteworthy participation of investors such as Magna Investment, SL Investment, and the Korea Entrepreneurship Foundation reflects the industry's confidence in the potential of NEURIVE's innovative concept and technology. With its strong focus on addressing the evolving needs of the medical field, NEURIVE's value proposition holds great promise for the future of digital medical platforms.

Business keywords: Digital Medical Platforms, Electroceuticals, Vagus Nerve Stimulation, Non-invasive Medical Devices, Medical Device Innovation, Biomedical Research, Life Science Research, Medical Device Manufacturing, Software Development, Biotechnology Research, Healthcare Innovation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round KRW1.00B 3
Magna Investment SL Investment
Magna Investment, SL Investment +1
26 Sep 2021
Non Equity Assistance Undisclosed 1
TIPS Program
01 Jun 2020
Seed Round KRW200.00M -
01 May 2020

NEURIVE Alternatives & Competitors

View All Alternatives
NEURIVE vs
Tesu Health
Tesu Health United Kingdom

Evidence-based digital therapeutics platform for personalised management of chronic diseases.

3 employees
Biotechnology, Digital Health
NEURIVE vs
Nanortopedi
Nanortopedi Turkey

Develops tailored healthcare solutions for distinct patient populations.

Venture round
Biotechnology, Deep Tech
NEURIVE vs
infrared.soft
infrared.soft Turkey

Medical thermography applications in English focus on advanced imaging techniques to detect and diag...

1 employees
Computer Vision, Digital Health
View all alternatives

FAQ About NEURIVE

A front runner for digital medical platform
NEURIVE was founded in 2018.
NEURIVE is headquartered in Korea South.
NEURIVE operates in Digital Health and Health and Wellness. Its work centres on Digital Medical Platforms, Electroceuticals, Vagus Nerve Stimulation and Non-invasive Medical Devices.
NEURIVE has approximately 6 employees.
NEURIVE has completed 3 funding rounds, raising a total of $1.20B. The latest funding stage is Seed.
Top alternatives and competitors to NEURIVE include Tesu Health, Nanortopedi, infrared.soft, Dawn Health, Stericool. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NEURIVE and Tesu Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NEURIVE, https://bouncewatch.com/company/neurive, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes